Literature DB >> 1265613

Role of preoperative bone scan in carcinoma of the breast.

A A El-Domeiri, S Shroff.   

Abstract

Although a skeletal scan is an effective means of detecting early metastatic deposits from carcinoma of the breast, its indiscriminate use in screening patients with early tumors does not seem justified because of the low yield of abnormal results. Selection of patients for this procedure should be based on the size of the tumor and the clinical stage of the disease. It is extremely unlikely that patients with a T1 lesion will have an abnormal skeletal scan. A preoperative scan in indicated for T2 lesions in patients with a central or medial quadrant mass, inflammatory carcinoma, palpable axillary lymph nodes or other clinical evidence suggestive of spread beyond breast tissue. All patients with T3 and inoperable tumors should have a bone scan prior to therapy to define the extent of the disease. A routine postoperative scan at six month intervals may be considered only in patients with large primary lesions and involvement of regional lymph nodes.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 1265613

Source DB:  PubMed          Journal:  Surg Gynecol Obstet        ISSN: 0039-6087


  4 in total

1.  An evaluation of bone scans as screening procedures for occult metastases in primary breast cancer.

Authors:  R R Baker; E R Holmes; P O Alderson; N F Khouri; H N Wagner
Journal:  Ann Surg       Date:  1977-09       Impact factor: 12.969

2.  Review of general surgery 1976.

Authors:  H Ellis
Journal:  Postgrad Med J       Date:  1977-04       Impact factor: 2.401

3.  Routine bone scanning in patients with T1 and T2 breast cancer: a waste of money.

Authors:  K A Yeh; L Fortunato; J A Ridge; J P Hoffman; B L Eisenberg; E R Sigurdson
Journal:  Ann Surg Oncol       Date:  1995-07       Impact factor: 5.344

4.  Problems associated with the detection of skeletal metastases.

Authors:  C S Galasko
Journal:  J R Soc Med       Date:  1978-01       Impact factor: 18.000

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.